Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S4X pseudogene 12 (RPS4XP12) is a pseudogene—a genomic DNA sequence similar to a functional gene but generally non-functional in terms of encoding an active protein[3][5]. It is designated “psuedogene” because it does not produce a functional ribosomal protein and is one of several processed pseudogenes related to the functional ribosomal protein S4, X-linked gene (RPS4X). Pseudogenes like RPS4XP12 are not considered therapeutic targets, have no protein product, and are not associated with cellular or therapeutic mechanisms, disease involvement, or drug interactions[2][3][5]. There is no evidence of an active role in normal biology or pathology, and there is no report of use as a biomarker or drug interaction partner. While the functional gene RPS4X (Ribosomal protein S4, X-linked) is a vital component of the ribosomal small subunit and is involved in protein synthesis with associations to Turner syndrome and other conditions, RPS4XP12 is a non-coding, non-functional pseudogene variant, which simply shares sequence homology with RPS4X but does not produce protein or exert biological effects[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S4X pseudogene 12 (RPS4XP12).